Co-Diagnostics, Inc. Share Price
NASDAQ: CODX | Micro CapCo-Diagnostics, Inc. Stock Performance
Co-Diagnostics, Inc. Share Price Today
As of 9 November 2026, Co-Diagnostics, Inc.'s share price is $0.27. The stock opened at $0.27, compared to its previous close of $0.25. During today's trading session, Co-Diagnostics, Inc.'s share price traded between $0.27 and $0.27, with an average price of $0.27. Over the past 52 weeks, the stock has recorded a high of $13.51 and a low of $0.17. In terms of performance, Co-Diagnostics, Inc.'s share price has declined by 96.73% over the last six months and is down 42.87% on a year-on-year basis.
Co-Diagnostics, Inc. Share Price Chart
Co-Diagnostics, Inc. Quarterly Profit & Loss
All figures in USD
Co-Diagnostics, Inc. Annual Profit & Loss
All figures in USD
About Co-Diagnostics, Inc.
Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
Co-Diagnostics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $0.38 | $0.27 | -27.37% |
Oct 2026 | $1.09 | $0.37 | -65.51% |
Sep 2026 | $1.20 | $1.07 | -15.75% |
Aug 2026 | $1.48 | $1.27 | -13.01% |
Jul 2026 | $3.40 | $1.46 | -51.97% |
Jun 2026 | $6.83 | $3.04 | -62.97% |
May 2026 | $1.53 | $8.21 | +419.62% |
Apr 2026 | $1.62 | $1.58 | -16.40% |
Mar 2026 | $3.60 | $1.89 | -22.22% |
Jan 2026 | $5.26 | $2.43 | +1,346.43% |
Dec 2025 | $0.35 | $0.17 | -54.96% |
Nov 2025 | $0.45 | $0.37 | -20.64% |